These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36121900)

  • 1. Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon.
    Veletzky L; Eberhardt KA; Hergeth J; Stelzl DR; Zoleko Manego R; Mombo-Ngoma G; Kreuzmair R; Burger G; Adegnika AA; Agnandji ST; Matsiegui PB; Boussinesq M; Mordmüller B; Ramharter M
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010793. PubMed ID: 36121900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of disease in Gabon caused by loiasis: a cross-sectional survey.
    Veletzky L; Hergeth J; Stelzl DR; Mischlinger J; Manego RZ; Mombo-Ngoma G; McCall MBB; Adegnika AA; Agnandji ST; Metzger WG; Matsiegui PB; Lagler H; Mordmüller B; Budke C; Ramharter M
    Lancet Infect Dis; 2020 Nov; 20(11):1339-1346. PubMed ID: 32585133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG4 serology of loiasis in three villages in an endemic area of south-eastern Gabon.
    Touré FS; Egwang TG; Millet P; Bain O; Georges AJ; Wahl G
    Trop Med Int Health; 1998 Apr; 3(4):313-7. PubMed ID: 9623933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low diagnostic performance of thick blood smears of 50 µl in comparison with direct examination of 10 µl blood and the leukoconcentration technique of 5ml blood among loiasis-suspected patients with low microfilaremia in Gabon, Central Africa, using the STARD-BLCM guidelines.
    M'Bondoukwé NP; Owono-Medang M; Moussavou-Boussougou MN; Akoue Y; Migueba V; Bulaev D; Neven A; James LAJ; Ntsame Ella SA; Mawili-Mboumba DP; Atsame J; Vaillant M; Bouyou Akotet MK
    Parasit Vectors; 2024 Mar; 17(1):138. PubMed ID: 38491557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imported Loa loa filariasis: three cases and a review of cases reported in non-endemic countries in the past 25 years.
    Antinori S; Schifanella L; Million M; Galimberti L; Ferraris L; Mandia L; Trabucchi G; Cacioppo V; Monaco G; Tosoni A; Brouqui P; Gismondo MR; Giuliani G; Corbellino M
    Int J Infect Dis; 2012 Sep; 16(9):e649-62. PubMed ID: 22784545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis.
    Ramharter M; Butler J; Mombo-Ngoma G; Nordmann T; Davi SD; Zoleko Manego R
    Lancet Infect Dis; 2024 Mar; 24(3):e165-e178. PubMed ID: 37858326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of diagnostic test outcomes in a large loiasis cohort from an endemic region: Serological tests are often false negative in hyper-microfilaremic infections.
    Veletzky L; Eberhardt KA; Hergeth J; Stelzl DR; Zoleko Manego R; Kreuzmair R; Burger G; Mischlinger J; McCall MBB; Mombo-Ngoma G; Adegnika AA; Agnandji ST; Matsiegui PB; Lell B; Kremsner P; Mordmüller B; Tappe D; Ramharter M
    PLoS Negl Trop Dis; 2024 Mar; 18(3):e0012054. PubMed ID: 38484012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between microfilaraemic and amicrofilaraemic loiasis involving co-infection with Mansonella perstans and clinical symptoms in an exposed population from Gabon.
    Bouyou Akotet MK; Owono-Medang M; Mawili-Mboumba DP; Moussavou-Boussougou MN; Nzenze Afène S; Kendjo E; Kombila M
    J Helminthol; 2016 Jul; 90(4):469-75. PubMed ID: 26268068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon.
    Akue JP; Nkoghe D; Padilla C; Moussavou G; Moukana H; Mbou RA; Ollomo B; Leroy EM
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1329. PubMed ID: 22022623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the intensity of Loa loa filariasis transmission and prevalence of infections].
    Toure FS; Deloron P; Egwang TG; Wahl G
    Med Trop (Mars); 1999; 59(3):249-52. PubMed ID: 10701202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural and clinical predictors for Loiasis.
    Mischlinger J; Veletzky L; Tazemda-Kuitsouc GB; Pitzinger P; Matsegui PB; Gmeiner M; Lagler H; Gebru T; Held J; Mordmüller B; Ramharter M
    J Glob Health; 2018 Jun; 8(1):010413. PubMed ID: 29497506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of knowledge, attitude and practice towards loiasis in the rural community of Sindara, in central African Gabon.
    Hildebrandt TR; Davi SD; Kabwende AL; Endamne LR; Mehmel E; Rakotonirinalalao M; Alabi A; Manego RZ; Kremsner PG; Lell B; Adegnika AA; Mombo-Ngoma G; Mischlinger J; Agnandji ST; Ramharter M
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012109. PubMed ID: 38781277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loa loa Infection in Pregnant Women, Gabon.
    Mombo-Ngoma G; Mackanga JR; Basra A; Capan M; Manego RZ; Adegnika AA; Lötsch F; Yazdanbakhsh M; González R; Menendez C; Mabika B; Matsiegui PB; Kremsner PG; Ramharter M
    Emerg Infect Dis; 2015 May; 21(5):899-901. PubMed ID: 25897819
    [No Abstract]   [Full Text] [Related]  

  • 14. Human occult loiasis: field evaluation of a nested polymerase chain reaction assay for the detection of occult infection.
    Touré FS; Mavoungou E; Kassambara L; Williams T; Wahl G; Millet P; Egwang TG
    Trop Med Int Health; 1998 Jun; 3(6):505-11. PubMed ID: 9657514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).
    Mogoung-Wafo AE; Nana-Djeunga HC; Domche A; Fossuo-Thotchum F; Bopda J; Mbickmen-Tchana S; Djomo-Kamga H; Kamgno J
    BMC Infect Dis; 2019 Feb; 19(1):146. PubMed ID: 30760228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of two serodiagnostic tests for loiasis in a Non-Endemic area.
    Gobbi F; Buonfrate D; Boussinesq M; Chesnais CB; Pion SD; Silva R; Moro L; Rodari P; Tamarozzi F; Biamonte M; Bisoffi Z
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008187. PubMed ID: 32453734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cutaneous filariasis Loa Loa: 26 moroccan cases of importation].
    El Haouri M; Erragragui Y; Sbai M; Alioua Z; Louzi ; El Mellouki W; Sedrati O
    Ann Dermatol Venereol; 2001 Sep; 128(8-9):899-902. PubMed ID: 11590341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Southern Nigeria
    Emukah E; Rakers LJ; Kahansim B; Miri ES; Nwoke BEB; Griswold E; Saka Y; Anagbogu I; Davies E; Ityonzughul C; D'Ambrosio M; Bakalar M; Fletcher DA; Nutman T; Kamgno J; Richards FO
    Am J Trop Med Hyg; 2018 Jul; 99(1):116-123. PubMed ID: 29761763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loa loa infection as a cause of migratory angioedema: report of three cases from the Texas Medical Center.
    Rakita RM; White AC; Kielhofner MA
    Clin Infect Dis; 1993 Oct; 17(4):691-4. PubMed ID: 8268351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.